Literature DB >> 17547829

Does antiretroviral therapy prevent HIV transmission to sexual partners?

Tahaniyat Lalani1, Charles Hicks.   

Abstract

The majority of HIV-1 infections are acquired sexually, and interventions to prevent sexual transmission are urgently needed to curb the growth of the HIV pandemic. The potential role of antiretroviral therapy in preventing sexual transmission of HIV is still emerging. Highly active antiretroviral therapy has been shown to decrease HIV RNA shedding in the genital tract, and its use among serodiscordant couples has been associated with reduced seroconversions in partners who are HIV negative. However, other studies have associated the use of antiretroviral therapy with increased HIV transmission risk behaviors. In this review, we explore the rationale for using highly active antiretroviral therapy to prevent sexual transmission of HIV including its role in prevention strategies at the population level, as well as the cost-effectiveness and potential limitations of this approach.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547829     DOI: 10.1007/s11904-007-0012-y

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  29 in total

1.  Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner.

Authors:  M A Pedraza; J del Romero; F Roldán; S García; M C Ayerbe; A R Noriega; J Alcamí
Journal:  J Acquir Immune Defic Syndr       Date:  1999-06-01       Impact factor: 3.731

Review 2.  Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?

Authors:  J X Velasco-Hernandez; H B Gershengorn; S M Blower
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

3.  HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia.

Authors:  Kimberly Page-Shafer; Vonthanak Saphonn; Ly Penh Sun; Mean Chhi Vun; David A Cooper; John M Kaldor
Journal:  Lancet       Date:  2005-09-01       Impact factor: 79.321

4.  Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

Authors:  Jesús Castilla; Jorge Del Romero; Victoria Hernando; Beatriz Marincovich; Soledad García; Carmen Rodríguez
Journal:  J Acquir Immune Defic Syndr       Date:  2005-09-01       Impact factor: 3.731

Review 5.  The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.

Authors:  Julio S G Montaner; Robert Hogg; Evan Wood; Thomas Kerr; Mark Tyndall; Adrian R Levy; P Richard Harrigan
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

6.  A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Authors:  S M Blower; H B Gershengorn; R M Grant
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

7.  Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months.

Authors:  Susan Cu-Uvin; Brad Snyder; Joseph I Harwell; Joseph Hogan; Carla Chibwesha; Dawn Hanley; Jessica Ingersoll; Jaclynn Kurpewski; Kenneth H Mayer; Angela M Caliendo
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

8.  Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand.

Authors:  Sodsai Tovanabutra; Valerie Robison; Jeerang Wongtrakul; Supaluk Sennum; Vinai Suriyanon; Duangnapa Kingkeow; Surinda Kawichai; Praijitr Tanan; Ann Duerr; Kenrad E Nelson
Journal:  J Acquir Immune Defic Syndr       Date:  2002-03-01       Impact factor: 3.731

9.  Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-04-18       Impact factor: 17.586

10.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

View more
  5 in total

1.  HIV+ women's narratives of non-disclosure: resisting the label of immorality.

Authors:  Allison Kjellman Groves; Suzanne Maman; Dhayendre Moodley
Journal:  Glob Public Health       Date:  2012-05-17

2.  Determinants of HIV shedding in the lower genital tract of women.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

3.  Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention.

Authors:  S C Kalichman; L Eaton; C Cherry
Journal:  HIV Med       Date:  2010-03-01       Impact factor: 3.180

Review 4.  Secondary prevention of HIV in the United States: past, current, and future perspectives.

Authors:  Jeffrey D Fisher; Laramie R Smith; Erin M Lenz
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

5.  Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract.

Authors:  Nonhlanhla N Nkwanyana; Pamela P Gumbi; Lindi Roberts; Lynette Denny; Willem Hanekom; Andreia Soares; Bruce Allan; Anna-Lise Williamson; David Coetzee; Abraham J Olivier; Wendy A Burgers; Jo-Ann Passmore
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.